Register
ISSN 1000-6818CN 11-1892/O6CODEN WHXUEU
Acta Phys Chim Sin >> 2016,Vol.32>> Issue(10)>> 2606-2619     doi: 10.3866/PKU.WHXB201606202         中文摘要
Improved Docking-Based Virtual Screening Using the Score Correction Strategy for Specific Endothelial Lipase Inhibitors Identification
LUO Qi-Yao, WANG Zi-Yun, JIN Hong-Wei, LIU Zhen-Ming, ZHANG Liang-Ren
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, P. R. China
Full text: PDF (21702KB) HTML Export: BibTeX | EndNote (RIS)

Endothelial lipase (EL) has been implicated in high-density lipoprotein (HDL) metabolism and the pathogenetic progress of atherosclerosis, so its specific inhibitors are expected to be useful for the treatment of cardiovascular disease. In addition to the high homology of EL with other lipases such as lipoprotein lipase (LPL), the scoring bias of current docking programs toward large molecules and large protein-binding pockets also makes it difficult to find specific EL inhibitors by docking-based virtual screening. Herein, we conducted docking-based virtual screening of the Specs database for EL and LPL firstly, and we found the scoring bias phenomenon. From the docking results of the Specs database, we established standard curves for the binding energies of EL and LPL based on heavy atom number and contact area to correct the dock energy score statistically. We then validated the correctional effects of these curves in the screening of a validation set. Furthermore, the traditional Chinese medicine database (TCMD) was screened by docking using the score correction strategy. The dock ranks before and after correction were compared to confirm the screening effectiveness. Moreover, some compounds exhibiting better affinity for EL than LPL after correction as well as some compounds with antihyperlipidemic activity that may be specific EL inhibitors were analyzed to study their interaction mechanisms. The developed score correction strategy should be helpful to improve the hit rate in docking-based virtual screening. The molecules we identified should be useful for experimental scientists to prioritize drug candidates and provide groundwork for potential therapies of hyperlipidemia and atherosclerosis.



Keywords: Endothelial lipase   Lipoprotein lipase   Specific inhibitor   Molecular docking   Score correction   Standard curve  
Received: 2016-04-21 Accepted: 2016-06-20 Publication Date (Web): 2016-06-20
Corresponding Authors: LIU Zhen-Ming, ZHANG Liang-Ren Email: zmliu@bjmu.edu.cn;liangren@bjmu.edu.cn

Fund: The project was supported by the National Natural Science Foundation of China (21572010, 21272017).

Cite this article: LUO Qi-Yao, WANG Zi-Yun, JIN Hong-Wei, LIU Zhen-Ming, ZHANG Liang-Ren. Improved Docking-Based Virtual Screening Using the Score Correction Strategy for Specific Endothelial Lipase Inhibitors Identification[J]. Acta Phys. -Chim. Sin., 2016,32 (10): 2606-2619.    doi: 10.3866/PKU.WHXB201606202

(1) Hirata, K.; Dichek, H. L.; Cioffi, J. A.; Choi, S. Y.; Leeper, N.J.; Quintana, L.; Kronmal, G. S.; Cooper, A. D.; Quertermous, T. J. Biol. Chem. 1999, 274 (20), 14170. doi: 10.1074/jbc.274.20.14170
(2) Jaye, M.; Lynch, K. J.; Krawiec, J.; Marchadier, D.; Maugeais, C.; Doan, K.; South, V.; Amin, D.; Perrone, M.; Rader, D. J.Nat. Genet. 1999, 21 (4), 424. doi: 10.1038/7766
(3) Wong, H.; Schotz, M. C. J. Lipid. Res. 2002, 43 (7), 993. doi: 10.1194/jlr.R200007-JLR200
(4) Fan, J.; Wang, J.; Bensadoun, A.; Lauer, S. J.; Dang, Q.; Mahley, R.W.; Taylor, J. M. Proc. Natl. Acad. Sci. U. S. A. 1994, 91 (18), 8724. doi: 10.1073/pnas.91.18.8724
(5) Zhang, J.; Yu, Y.; Nakamura, K.; Koike, T.; Waqar, A. B.; Zhang, X.; Liu, E.; Nishijima, K.; Kitajima, S.; Shiomi, M.; Qi, Z.; Yu, J.; Graham, M. J.; Crooke, R. M.; Ishida, T.; Hirata, K.; Hurt-Camejo, E.; Chen, Y. E.; Fan, J. J. Atheroscler. Thromb. 2012, 19 (3), 213. doi: 10.5551/jat.11148
(6) Goldberg, I. J. J. Lipid. Res. 1996, 37 (4), 693.
(7) Ichikawa, T.; Liang, J.; Kitajima, S.; Koike, T.; Wang, X.; Sun, H.; Morimoto, M.; Shikama, H.; Watanabe, T.; Yamada, N.; Fan, J. Atherosclerosis 2005, 179 (1), 87. doi: 10.1016/j.atherosclerosis.2004.10.044
(8) Nong, Z.; Gonzalez-Navarro, H.; Amar, M.; Freeman, L.; Knapper, C.; Neufeld, E. B.; Paigen, B. J.; Hoyt, R. F.; Fruchart-Najib, J.; Santamarina-Fojo, S. J. Clin. Invest. 2003, 112 (3), 367. doi: 10.1172/JCI200316484
(9) Tsutsumi, K.; Inoue, Y.; Shima, A.; Iwasaki, K.; Kawamura, M.; Murase, T. J. Clin. Invest. 1993, 92 (1), 411. doi: 10.1172/JCI116582
(10) Dalan, A. B.; Toptas, B.; Bugra, Z.; Polat, N.; Yilmaz-Aydogan, H.; Cimen, A.; Isbir, T. Mol. Biol. Rep. 2013, 40 (8), 5143. doi: 10.1007/s11033-013-2615-2
(11) Merkel, M.; Eckel, R. H.; Goldberg, I. J. J. Lipid. Res. 2002, 43 (12), 1997. doi: 10.1194/jlr.R200015-JLR200
(12) McCoy, M. G.; Sun, G. S.; Marchadier, D.; Maugeais, C.; Glick, J. M.; Rader, D. J. J. Lipid. Res. 2002, 43 (6), 921.
(13) Connelly, P.W. Clin. Chim. Acta 1999, 286 (1), 243. doi: 10.1016/S0009-8981(99)00105-9
(14) Martinez, L. O.; Jacquet, S.; Terce, F.; Collet, X.; Perret, B.; Barbaras, R. Cell Mol. Life Sci. 2004, 61 (18), 2343. doi: 10.1007/s00018-004-4087-y
(15) Ishida, T.; Choi, S.; Kundu, R. K.; Hirata, K.; Rubin, E. M.; Cooper, A. D.; Quertermous, T. J. Clin. Invest. 2003, 111 (3), 347. doi: 10.1172/JCI200316306
(16) Tatematsu, S.; Francis, S. A.; Natarajan, P.; Rader, D. J.; Saghatelian, A.; Brown, J. D.; Michel, T.; Plutzky, J.Arterioscler. Thromb. Vasc. Biol. 2013, 33 (8), 1788. doi: 10.1161/ATVBAHA.113.301300
(17) Annema, W.; Tietge, U. J. Curr. Atheroscler. Rep. 2011, 13 (3), 257. doi: 10.1007/s11883-011-0175-2
(18) Degoma, E. M.; Rader, D. J. Nat. Rev. Cardiol. 2011, 8 (5), 266. doi: 10.1038/nrcardio.2010.200
(19) Nardini, M.; Dijkstra, B.W. Curr. Opin. Struct. Biol. 1999, 9 (6), 732. doi: 10.1016/S0959-440X(99)00037-8
(20) Brenner, S. Nature 1988, 334 (6182), 528. doi: 10.1038/334528a0
(21) Derewenda, Z. S.; Derewenda, U. Biochem. Cell Biol. 1991, 69 (12), 842. doi: 10.1139/o91-125
(22) Emmerich, J.; Beg, O. U.; Peterson, J.; Previato, L.; Brunzell, J.D.; Brewer, H. B., Jr.; Santamarina-Fojo, S. J. Biol. Chem. 1992, 267 (6), 4161.
(23) Davis, R. C.; Stahnke, G.; Wong, H.; Doolittle, M. H.; Ameis, D.; Will, H.; Schotz, M. C. J. Biol. Chem. 1990, 265 (11), 6291.
(24) Lowe, M. E. J. Biol. Chem. 1992, 267 (24), 17069.
(25) Wang, Z.; Li, S.; Sun, L.; Fan, J.; Liu, Z. PLoS One 2013, 8 (8), e72146. doi: 10.1371/journal.pone.0072146
(26) Greco, M. N.; Connelly, M. A.; Leo, G. C.; Olson, M.W.; Powell, E.; Huang, Z.; Hawkins, M.; Smith, C.; Schalk-Hihi, C.; Darrow, A. L.; Xin, H.; Lang, W.; Damiano, B. P.; Hlasta, D. J.Bioorg. Med. Chem. Lett. 2013, 23 (9), 2595. doi: 10.1016/j.bmcl.2013.02.113
(27) Sun, S.; Dean, R.; Jia, Q.; Zenova, A.; Zhong, J.; Grayson, C.; Xie, C.; Lindgren, A.; Samra, P.; Sojo, L.; van Heek, M.; Lin, L.; Percival, D.; Fu, J. M.; Winther, M. D.; Zhang, Z. Bioorg. Med. Chem. 2013, 21 (24), 7724. doi: 10.1016/j.bmc.2013.10.023
(28) Goodman, K. B.; Bury, M. J.; Cheung, M.; Cichy-Knight, M.A.; Dowdell, S. E.; Dunn, A. K.; Lee, D.; Lieby, J. A.; Moore, M. L.; Scherzer, D. A.; Sha, D.; Suarez, D. P.; Murphy, D. J.; Harpel, M. R.; Manas, E. S.; McNulty, D. E.; Annan, R. S.; Matico, R. E.; Schwartz, B. K.; Trill, J. J.; Sweitzer, T. D.; Wang, D. Y.; Keller, P. M.; Krawiec, J. A.; Jaye, M. C. Bioorg. Med. Chem. Lett. 2009, 19 (1), 27. doi: 10.1016/j.bmcl.2008.11.033
(29) O'Connell, D. P.; LeBlanc, D. F.; Cromley, D.; Billheimer, J.; Rader, D. J.; Bachovchin, W.W. Bioorg. Med. Chem. Lett. 2012, 22 (3), 1397. doi: 10.1016/j.bmcl.2011.12.043
(30) Abdel-Magid, A. F. ACS Med. Chem. Lett. 2013, 4 (11), 1016. doi: 10.1021/ml400361q
(31) Jensen, M. K.; Rimm, E. B.; Mukamal, K. J.; Edmondson, A.C.; Rader, D. J.; Vogel, U.; Tjonneland, A.; Sorensen, T. I.; Schmidt, E. B.; Overvad, K. Eur. Heart J. 2009, 30 (13), 1584. doi: 10.1093/eurheart/ehp145
(32) Tanaka, H.; Ishida, T.; Johnston, T. P.; Yasuda, T.; Ueyama, T.; Kojima, Y.; Kundu, R. K.; Quertermous, T.; Ishikawa, Y.; Hirata, K. J. Atheroscler. Thromb. 2009, 16 (4), 327. doi: 10.5551/jat.No844
(33) Fan, J.; Unoki, H.; Kojima, N.; Sun, H.; Shimoyamada, H.; Deng, H.; Okazaki, M.; Shikama, H.; Yamada, N.; Watanabe, T.J. Biol. Chem. 2001, 276 (43), 40071. doi: 10.1074/jbc.M105456200
(34) Jin, W.; Millar, J. S.; Broedl, U.; Glick, J. M.; Rader, D. J. J. Clin. Invest. 2003, 111 (3), 357. doi: 10.1172/JCI200316146
(35) Wallach, I.; Jaitly, N.; Nguyen, K.; Schapira, M.; Lilien, R. J. Chem. Inf. Model. 2011, 51 (8), 1817. doi: 10.1021/ci200175h
(36) Jacobsson, M.; Karlen, A. J. Chem. Inf. Model. 2006, 46 (3), 1334. doi: 10.1021/ci050407t
(37) LigPrep2.6; Schrödinger, LLC: New York, 2013.
(38) Pipeline Pilot 7.5; Accelrys Software Inc.: San Diego, CA, USA. http://accelrys.com (accessed January 25, 2015).
(39) Discovery Studio 2.5; Accelrys Software Inc.: San Diego, CA, USA. http://accelrys.com (accessed January 25, 2015).
(40) Cereto-Massague, A.; Guasch, L.; Valls, C.; Mulero, M.; Pujadas, G.; Garcia-Vallve, S. Bioinformatics 2012, 28 (12), 1661. doi: 10.1093/bioinformatics/bts249
(41) He, M.; Yan, X.; Zhou, J.; Xie, G. J. Chem. Inf. Model. 2001, 41 (2), 273. doi: 10.1021/ci0003101
(42) Trott, O.; Olson, A. J. J. Comput. Chem. 2010, 31 (2), 455. doi: 10.1002/jcc.21334
(43) Bicherton, G. R.; Paolini, G. V.; Besnard, J.; Muresan, S.; Hopkins, A. L. Nat. Chem. 2012, 4 (2), 90. doi: 10.1038/nchem.1243
(44) Newman, D. J.; Cragg, G. M. J. Nat. Prod. 2007, 70 (3), 461. doi: 10.1021/np068054v

1. DENG Yu-Ling, YU Lu, HUANG Qiang.A Multi-Target Docking System of Human Kinome[J]. Acta Phys. -Chim. Sin., 2016,32(9): 2355-2363
2. XU Shi-Wen, LIN Dong-Qiang, YAO Shan-Jing.Evaluation of Molecular Binding Modes on Site II of Human Serum Albumin[J]. Acta Phys. -Chim. Sin., 2016,32(7): 1819-1828
3. LIN Feng, FU Xin-Mei, WANG Chao, JIANG Si-Yu, WANG Jing-Hui, ZHANG Shu-Wei, YANG Ling, LI Yan.QSAR, Molecular Docking and Molecular Dynamics of 3C-like Protease Inhibitors[J]. Acta Phys. -Chim. Sin., 2016,32(11): 2693-2708
4. HE Bing, LUO Yong, LI Bing-Ke, XUE Ying, YU Luo-Ting, QIU Xiao-Long, YANG Teng-Kuei.Predicting and Virtually Screening Breast Cancer Targeting Protein HEC1 Inhibitors by Molecular Descriptors and Machine Learning Methods[J]. Acta Phys. -Chim. Sin., 2015,31(9): 1795-1802
5. ZHANG Shu-Zhen, ZHENG Chao, ZHU Chang-Jin.Molecular Docking and Receptor-Based 3D-QSAR Studies on Aromatic Thiazine Derivatives as Selective Aldose Reductase Inhibitors[J]. Acta Phys. -Chim. Sin., 2015,31(12): 2395-2404
6. LIU Hai-Chun, LU Shuai, RAN Ting, ZHANG Yan-Min, XU Jin-Xing, XIONG Xiao, XU An-Yang, LU Tao, CHEN Ya-Dong.Accurate Activity Predictions of B-Raf Type II Inhibitors via Molecular Docking and QSAR Methods[J]. Acta Phys. -Chim. Sin., 2015,31(11): 2191-2206
7. LI Bing-Ke, CONG Yong, TIAN Zhi-Yue, XUE Ying.Predicting and Virtually Screening the Selective Inhibitors of MMP-13 over MMP-1 by Molecular Descriptors and Machine Learning Methods[J]. Acta Phys. -Chim. Sin., 2014,30(1): 171-182
8. KANG Cong-Min, ZHAO Xu-Hao, WANG Xin-Yu, CHENG Jia-Gao, LÜ Ying-Tao.QSAR and Molecular Docking on Five-Membered Heterocyclopyrimidines as Thymidylate Synthase Inhibitors[J]. Acta Phys. -Chim. Sin., 2013,29(02): 431-438
9. BAI Shu, ZHOU Rong, LIU Fu-Feng.Rational Design of Affinity Ligand for the Oriented Immobilization of Trypsin[J]. Acta Phys. -Chim. Sin., 2013,29(02): 439-448
10. HUANG Yang-Yu, YANG Xiu-Feng, LI Hao-Tian, JI Xiao-Feng, CHENG Hong-Li, ZHAO Yun-Jie, GUO Da-Chuan, LI Lin, LIU Shi-Yong.Protein-RNA Interaction Interface Prediction and Design[J]. Acta Phys. -Chim. Sin., 2012,28(10): 2390-2400
11. QIAO Kang, ZENG Ling-Xiao, JIN Hong-Wei, LIU Zhen-Ming, ZHANG Liang-Ren.QSAR Analysis of Human Adenosine A3 Receptor Antagonists[J]. Acta Phys. -Chim. Sin., 2012,28(06): 1509-1519
12. HU Yan-Bao, PENG Jing-Bo, GU Shuo, PEI Jian-Feng, ZOU Zhong-Mei.Molecular Docking in Xin-Ke-Shu Preparation's Multi-Target Effect on Coronary Heart Disease[J]. Acta Phys. -Chim. Sin., 2012,28(05): 1257-1264
13. WANG Cun-Xin, CHANG Shan, GONG Xin-Qi, YANG Feng, LI Chun-Hua, CHEN Wei-Zu.Progress in the Scoring Functions of Protein-Protein Docking[J]. Acta Phys. -Chim. Sin., 2012,28(04): 751-758
14. SHEN Tao, DU Feng-Pei, LIU Ting, YAO Guang-Wei, WU Zheng, FANG Meng-Meng, XU Xiao-Jie, LU Hui-Zhe.Molecular Simulation of the Interaction between Imidazole Glycerol Phosphate Dehydrase and Nitrogen-Containing Heterocyclic Phosphate Inhibitors[J]. Acta Phys. -Chim. Sin., 2011,27(08): 1831-1838
15. ZHANG Yuan, CHEN Ya-Dong, YOU Qi-Dong, ZOU Li-Yun, YANG Yan.Homology Modeling and Molecular Docking Studies on the Selectivity of HDAC1/HDAC8[J]. Acta Phys. -Chim. Sin., 2010,26(06): 1676-1686
16. ZHENG Chun-Song, XU Xiao-Jie, LIU Xian-Xiang, YE Hong-Zhi.Computational Pharmacology of Jingzhi Tougu Xiaotong Granule in Preventing and Treating Osteoarthritis[J]. Acta Phys. -Chim. Sin., 2010,26(03): 775-783
17. LI Bo, LIU Ming, HU Wen-Xiang.Molecular Docking and Molecular Dynamics Simulations of Fentanyl Analogs Binding to μ-Opioid Receptors[J]. Acta Phys. -Chim. Sin., 2010,26(01): 206-214
18. LIU Tao, SUN Mao-Tang, DONG Xiao-Wu, REN Xin, YANG Xin, DU Li-Lin, HU Yong-Zhou.Structure-Based Drug Design, Synthesis and Antitumor Activities of Novel CDK7 Inhibitors[J]. Acta Phys. -Chim. Sin., 2009,25(10): 2107-2112
19. JIANG Yu-Ren, XU Hui, CHEN Fang-Jun, MA Guan-Jun.Molecular Docking of the Acetylcholinesterase Inhibitor Corydaline and Virtual Screening of Open Ring Derivatives[J]. Acta Phys. -Chim. Sin., 2009,25(07): 1379-1384
20. LV Wen, LV Wei, NIU Yan, LEI Xiao-Ping.HomologyModeling andMolecular Docking on Muscarinic M1 Receptor[J]. Acta Phys. -Chim. Sin., 2009,25(07): 1259-1266
21. WEI Zhuo, ZHANG Huai, CUI Wei, JI Ming-Juan.Molecular Docking and 3D-QSAR on Maleimide Derivatives as Glycogen Synthase Kinase-3β Inhibitors[J]. Acta Phys. -Chim. Sin., 2009,25(05): 890-896
22. SUN Ni-Yue, LU Tao, CHEN Ya-Dong, HAO Lan-Hu, XU Yan, LI Rui-Jun.3D-QSAR and Molecular Docking Study on Selectivity of Indolocarbazole Series as Cyclin-Dependent Kinase Inhibitors[J]. Acta Phys. -Chim. Sin., 2009,25(04): 645-654
23. ZHAO Yong-Shan, ZHENG Qing-Chuan, ZHANG Hong-Xing, CHU Hui-Ying, SUN Chia-Chung.Homology Modeling of Human Serine Racemase and Its Molecular Docking with Peptide Inhibitors[J]. Acta Phys. -Chim. Sin., 2009,25(03): 417-422
24. XU Zhi-Guang; XU Xuan; YUAN Chuan-Neng.Molecular Docking on Taxotere Binding to αβ-Tubulin[J]. Acta Phys. -Chim. Sin., 2008,24(10): 1839-1844
25. YUAN Wei; LI He-Xian; WANG Ying; YANG Hai-Long; WANG Guo-Chang.Computer Simulation on Intermolecular Interaction of N-(1-naphthyl)-succinimide[J]. Acta Phys. -Chim. Sin., 2007,23(05): 630-634
26. LIU Zhen-ming; LI Bo; LAI Lu-hua.Functional Classification of Phospholipase A2 Family[J]. Acta Phys. -Chim. Sin., 2005,21(10): 1143-1145
27. LIU Hai-chun; ZOU Jian-wei; ZHANG Bing; ZHUANG Shu-lin; JIANG Yong-jun; YU Qing-sen.Homology Modeling of p-Hydroxymandelate Synthase and Its Molecular Docking with Substrate[J]. Acta Phys. -Chim. Sin., 2005,21(08): 852-856
28. LI Xu-Dong; HOU Ting-Jun; Xu Xiao-Jie.Comparative Studies of 14 Binding Free Energies Scoring Functions[J]. Acta Phys. -Chim. Sin., 2005,21(05): 504-507
29. LIU Bing; LU Ai-Jun; LIAO Chen-Zhong; LIU Hai-Bo; ZHOU Jia-Ju.3D-QSAR of Sulfonamide Hydroxamic Acid HDAC Inhibitors[J]. Acta Phys. -Chim. Sin., 2005,21(03): 333-337
Copyright © 2006-2016 Editorial office of Acta Physico-Chimica Sinica
Address: College of Chemistry and Molecular Engineering, Peking University, Beijing 100871, P.R.China
Service Tel: +8610-62751724 Fax: +8610-62756388 Email:whxb@pku.edu.cn
^ Top